| PERIOD ENDING | 29-Aug-09 | 9-May-09 | 14-Feb-09 | 22-Nov-08 | | Total Revenue | 2,232,494 | 1,658,161 | 1,447,877 | 1,478,292 | | Cost of Revenue | 1,109,441 | 825,253 | 728,580 | 737,101 | | | Gross Profit | 1,123,053 | 832,908 | 719,297 | 741,191 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 705,457 | 527,676 | 504,602 | 502,652 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 417,596 | 305,232 | 214,695 | 238,539 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,887 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 421,483 | 305,232 | 214,695 | 238,539 | | Interest Expense | 51,649 | 31,482 | 31,906 | 31,166 | | Income Before Tax | 369,834 | 273,750 | 182,789 | 207,373 | | Income Tax Expense | 133,708 | 100,062 | 66,925 | 76,002 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 236,126 | 173,688 | 115,864 | 131,371 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 236,126 | 173,688 | 115,864 | 131,371 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $236,126 | $173,688 | $115,864 | $131,371 |
|
1.29% Nasdaq 
Income Statement
